Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness
Maha N. Mian, Brianna R. Altman, Mitch Earleywine
Journal of Psychoactive Drugs September 30, 2019 DOI: 10.1080/02791072.2019.1674428 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Placebo-controlled Peer reviewed |
|---|---|
| Sample size | 152 |
| Population | Individuals after an Ayahuasca experience |
| Intervention | Ayahuasca |
| Topics | Anxiety Ayahuasca Meditation |
| Keywords | Behavioral activation Antidepressant Depression economics Hallucinogen Clinical psychology Behavioral inhibition Behavioral neuroscience Placebo Cognition |
| Citations | 47 |
| Key findings | Behavioral activation was a stronger predictor of reduced depression than mindfulness after an Ayahuasca experience. |
Abstract
Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on changes in mindfulness. This study investigated whether both mindfulness and behavioral activation might contribute to these anti-depressant effects. We surveyed individuals (N = 152) about their changes in depressive symptoms, behavioral activation, and mindfulness after an Ayahuasca experience. Mindfulness was strongly associated with reduced depression severity (r = - .670, p r = - .474, p p p < .05). Changes in behavioral activation likely serve as a mechanism underlying Ayahuasca's antidepressant effects. Future clinical trials could benefit from tracking behavioral activation.
Comparable studies
Other observational and cohort studies on ayahuasca for anxiety, most cited first.
Citations in the library
Cited by 38
- Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice. ACS Pharmacology & Translational Science March 16, 2021
- Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey. Frontiers in Pharmacology April 21, 2021
- LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model. Psychological Medicine March 1, 2023
- Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns Journal of Humanistic Psychology April 2, 2022
- Ayahuasca's therapeutic potential: What we know - and what not. European Neuropsychopharmacology 2023
and 33 more in the library
Cites 58
- Using Self-Report Assessment Methods to Explore Facets of Mindfulness Assessment January 27, 2006
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Psychological Medicine June 15, 2018
and 53 more in the library